With nearly 240 years of history behind it, Takeda continues to position itself as a leading global R&D-driven biopharmaceutical organization. Dr Mahender Nayak, recently appointed area head of India, the CIS countries, Middle East, Turkey, and Africa (ICMEA), explains the company’s strategic presence in the region and outlines his strategy to continue growing by staying loyal to Takeda’s values.
I believe that understanding the diversity of ICMEA is a big challenge, but it also presents a huge opportunity
